Complement factor I deficiency in a family with recurrent infections

Immunopharmacology

Volumn 38, Issue 1-2, 1997, Pages 207-213

  Leitao M F ^a   Vilela, M M S ^a   Rutz, R ^c   Grumach, A S ^b   Condino Neto, A ^a   Kirschfink, M ^c  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Bacterial infections; Complement; Factor H; Factor I deficiency

Indexed keywords

ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C3B; COMPLEMENT COMPONENT C3C; COMPLEMENT COMPONENT C3D; COMPLEMENT FACTOR H; COMPLEMENT FACTOR I; PROPERDIN;

ADULT; ARTICLE; BACTERIAL INFECTION; BRAZIL; CHEMOTAXIS; CHILD; CLINICAL ARTICLE; COMPLEMENT ALTERNATIVE PATHWAY; COMPLEMENT DEFICIENCY; FAMILY STUDY; FEMALE; HUMAN; MALE; OPSONIZATION; PHAGOCYTOSIS; PRIORITY JOURNAL; RECURRENT INFECTION;

ADOLESCENT; ADULT; BACTERIAL INFECTIONS; BRAZIL; CHILD; CHILD, PRESCHOOL; COMPLEMENT ACTIVATION; COMPLEMENT C3; COMPLEMENT FACTOR B; COMPLEMENT FACTOR H; COMPLEMENT FACTOR I; CONSANGUINITY; FEMALE; HUMANS; MALE; MENINGITIS, BACTERIAL; MIDDLE AGED; OTITIS MEDIA; PEDIGREE; PROPERDIN; RESPIRATORY TRACT INFECTIONS; SEPSIS;

EID: 0031445962     PISSN: 01623109     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0162-3109(97)00080-5     Document Type: Article

References (31)

1. Abramson, N., Alper, C.A., Lachmann, P.J., Rosen, F.S., Jandl, J.H., 1971. Deficiency of C3 inactivator in man. J. Immunol. 107, 19-27.
2. Alper, C.A., Abramson, N., Johnston, R.B. Jr., Jandl, J.H., Rosen, F.S., 1970. Studies in vivo and in vitro on an abnormality in the metabolism of C3 in a patient with increased susceptibility to infection. J. Clin. Invest. 49, 1975-1985.
3. Barrett, D.J., Boyle, M.D.P., 1984. Restoration of complement function in vivo by plasma infusion in factor I (C3b inactivator) deficiency. J. Pediatr. 104, 76-81.
4. Boyden, S.V. Jr., 1962. The chemotactic effect of mixtures of antibody and antigen in polymorphonuclear leukocytes. J. Exp. Med. 115, 453-466.
5. Brandslund, I., Siersted, H.C., Svehag, S.E., Teisner, B., 1981. Doubledecker rocket immunoelectrophoresis for direct quantitation of complement C3 split products with C3d specificities in plasma. J. Immunol. Methods 2. 63-71.
6. Di Scipio, R.G., 1992. Ultrastructures and interactions of complement factors H and I. J. Immunol. 149, 2592-2599.
7. Figueroa, J.E., Densen, P., 1991. Infectious diseases associated with complement deficiencies. Clin. Microbiol. Rev. 4, 359-395.
8. Floret, D., Stamm, D., Ponard, D., 1991. Increased susceptibility to infection in children with congenital deficiency of Factor I. Pediatr. Infect. Dis. J. 10, 615-618.
9. Grumach, A.S., Kirschfink, M., 1995. Complement and IgG sub-classes in agammaglobulinemic patients. Clin. Exp. Immuno-genetics 12, 10-15.
10. Joiner, K.A., Hawinger, A., Gelfand, J.A., 1983. A study of optimal reaction conditions for an assay of the human alternative complement pathway. Am. J. Clin. Pathol. 79, 65-72.
11. Kirschfink, M., Binder, R., 1997. Deficiencies in the alternative pathway: Factors I and H. In: Rother, K., Till, G.O., Hänsch, G.M. (Eds.), The Complement System. 2nd ed., pp. 420-427, in press.
12. Levy, L.R., Lepow, R.B., 1959. Assay and properties of serum inhibitor of Cl esterase. Proc. Soc. Exp. Biol. 101, 608-611.
13. Mayer, M.M., 1961. Complement and complement fixation. In: Kabat. E., Mayer, M.M. (Eds.), Experimental Immunochemistry. Charles C. Thomas, Springfield, pp. 133-240.
14. Møller-Rasmussen, J.M., Teisner, B., Jepsen, H.H., Svehag, S.E., Knudsen, F., Kirstein, H., Buhl, M., 1988. Three cases of factor I deficiency: The effect of treatment with plasma. Clin. Exp. Immunol. 74, 131-136.
15. Müller-Eberhard, H.J., 1988. Molecular organization and function of the complement system. Ann. Rev. Biochem. 57, 321-347.
16. Nagaki, K., lida. K., Okubo, M., Inai, S., 1978. Reaction mechanisms of β1H globulin. Int. Arch. Allergy Appl. Immunol. 57, 221-232.
17. Østergaard-Alsøe, K., Kihl, J., 1989. Pasteurization of a factor I (C3b inactivator) concentrate from human plasma. Vox Sang 57, 240-242.
18. Pangburn, M.K., Schreiber, R.D., Müller-Eberhard, H.J., 1977. Human Complement C3b inactivator: Isolation, characterization, and demonstration of an absolute requirement for the serum protein β1H for cleavage of C3b and C4b in solution. J. Exp. Med. 146, 257-271.
19. Pangburn, M.K., Schreiber, R.D., Müller-Eberhard. H.J., 1981. Formation of the initial C3 convertase of the alternative complement pathway. Acquisition of C3b-like activities by spontaneous hydrolysis of the putative thioester in native C3. J. Exp. Med. 154, 856-867.
20. Porteu, F., Fischer, A., Descamps-Latscha, B., Halbwachs-Mecarelli, L., 1986. Defective complement receptors (CR1 and CR3) on erythrocytes and leukocytes of factor I (C3b inactivator) deficient patients. Clin. Exp. Immunol. 66, 463-471.
21. Rasmussen, J.M., Teisner, B., Brandslund, I., Svehag. S.E., 1986. A family with complement factor I deficiency. Scand. J. Immunol. 23,711-715.
22. Rother, K., Rother, U., 1986. Hereditary and acquired deficiencies in animals and man. Karger, Basel.
23. Sim, R.B., Kölble, K., McAleer, M.A., Dominguez, O., Dee. V.M., 1993. Genetics and deficiencies of the soluble regulatory proteins of the complement system. Int. Rev. Immunol. 10, 65-86.
24. Solal-Celigny, P., Laviolette, M., Hebert, J., Atkins, P.C., Sirois, M., Brun, G., Lehner-Netsch, G., Delage, J.M., 1982. C3b inactivator deficiency with immune complex manifestations. Clin. Exp. Immunol. 47, 197-205.
25. Turner, M.W., 1996. Mannose-binding lectin: the pluripotent molecule of the innate immune system. Immunol Today 17, 532-540.
26. Van Furth, R., van Zwet, T.L., Leijh, P.C.J., 1978. In vitro determinations of phagocytosis and intracellular killing by polymorphonuclear and mononuclear phagocytes. In: Weir, D.M. (Ed.), Handbook of Experimental Immunology, 3rd ed. Blackwell Scientific Publications, Oxford, pp. 32.1-32.19.
27. Vyse, T.J., Späth, P.J., Davies, K.A., Morley, B.J., Philippe, P., Athanassiou, P., Giles, C.M., Walport, M.J., 1994. Hereditary complement factor I deficiency. Quart. J. Med. 87, 385-402.
28. Vyse, T.J., Morley, B.J., Bartok, I., Theodoridis, E.L., Davis, K.A., Webster, A.D.B., Walport, M.J., 1996. The molecular basis of hereditary complement factor I deficiency. J. Clin. Invest. 97, 925-933.
29. Wahn, V., Rother, U., Rauterberg, E.W., Day, N.K., Laurell, A.B., 1981. C3b inactivator deficiency: association with an alpha-migrating factor H. J. Clin. Immunol. 1, 228-233.
30. Whaley, K., Ruddy, S., 1976. Modulation of the alternative pathway by β1H globulin. J. Exp. Med. 144, 1147-1163.
31. Ziegler, J.B., Alper, C.A., Rosen, F.S., Lachmann, P.J., Sherington, L., 1975. Restoration by purified C3b inactivator of complement-mediated function in vivo in a patient with C3b inactivator deficiency. J. Clin. Invest. 55, 668-672.